Drug Topics - January 2009 - (Page 41)

CONTINUING EDUCATION EVALUATION OF CE Drug Topics is conducting an evaluation of this CE article. Please check the box that best re ects your opinion of the evaluation questions. Please keep this evaluation attached to your answer form. Strongly Agree 1. The objectives listed on page 33 were met. (If not, please explain.) Agree Disagree Strongly Disagree 2. 3. 4. 5. 6. The authors wrote a high-quality article. The materials were high quality and useful. The learning activity (quiz) was effective. The program content was useful and relevant. The program was educational and not promotional. 2009 CEU CREDIT REQUEST To obtain immediate CE credit, take the test online at www.drugtopics.com. Just click on the “Continuing Education” box on the Drug Topics home page, which will take you to the CE site. Log in, find and click on this lesson, and follow the three simple steps. Test results will be displayed immediately and you can print the certificate showing your earned CE credits. ANSWER FORM Community-acquired MRSA infections: CE quiz answers JANUARY 2009 ACPE # 012-999-08-188-H01-P ACPE # 012-999-08-188-H01-T Test questions start on page 40 1. 2. 3. 4. a. a. a. a. b. b. b. b. c. c. c. c. d. d. d. d. 5. 6. 7. 8. a. a. a. a. b. b. b. b. c. c. c. c. d. d. d. d. 9. 10. 11. 12. a. a. a. a. b. b. b. b. c. c. c. c. d. d. d. d. 13. 14. 15. 16. a. a. a. a. b. b. b. b. c. c. c. c. d. d. d. d. 17. 18. 19. 20. a. a. a. a. b. b. b. b. c. c. c. c. d. d. d. d. No longer valid for CE credit after 01/31/2011 Amount enclosed: $6.00 for this lesson $54.00 for any 12 lessons you take over the next year, starting from the date you sign up Already series-enrolled for 2009 For questions concerning PRINT CEs, call (352) 273-6275. For questions concerning ON-LINE CEs, call (866) 261-3558. Are you employed by a chain? If so, which one? Submit your check (payable to The University of Florida) and form to: University of Florida College of Pharmacy P.O.Box 113195, Gainesville, FL 32611-3195 E-mail address: continuinged@cop.ufl.edu Fees not refundable or transferable REGISTRANT INFORMATION Name: (Last) (First) (M.I.) Phone Address: (Street) E-mail address: State: Florida pharmacists: Please provide your license number ZIP: City: W W W.D R U GTO P I C S .C O M Januar y 2009 DRUG TOPICS 41 http://www.drugtopics.com http://WWW.DRUGTOPICS.COM

Table of Contents Feed for the Digital Edition of Drug Topics - January 2009

Drug Topics - January 2009 Contents Letters Up Front Up Front in Depth Community Practice Drug Pipeline: What to Watch in 2009 OTC Community-Aquired MRSA Infections New Products Viewpoint

Drug Topics - January 2009

Drug Topics - January 2009 - Drug Topics - January 2009 (Page Cover1) Drug Topics - January 2009 - Drug Topics - January 2009 (Page Cover2) Drug Topics - January 2009 - Drug Topics - January 2009 (Page 1) Drug Topics - January 2009 - Drug Topics - January 2009 (Page 2) Drug Topics - January 2009 - Drug Topics - January 2009 (Page 3) Drug Topics - January 2009 - Contents (Page 4) Drug Topics - January 2009 - Contents (Page 5) Drug Topics - January 2009 - Contents (Page 6) Drug Topics - January 2009 - Contents (Page 7) Drug Topics - January 2009 - Contents (Page 8) Drug Topics - January 2009 - Contents (Page 9) Drug Topics - January 2009 - Contents (Page 10) Drug Topics - January 2009 - Contents (Page 11) Drug Topics - January 2009 - Letters (Page 12) Drug Topics - January 2009 - Letters (Page H1) Drug Topics - January 2009 - Letters (Page H2) Drug Topics - January 2009 - Letters (Page H3) Drug Topics - January 2009 - Letters (Page H4) Drug Topics - January 2009 - Letters (Page H5) Drug Topics - January 2009 - Letters (Page H6) Drug Topics - January 2009 - Letters (Page H7) Drug Topics - January 2009 - Letters (Page H8) Drug Topics - January 2009 - Letters (Page 13) Drug Topics - January 2009 - Up Front (Page 14) Drug Topics - January 2009 - Up Front (Page 15) Drug Topics - January 2009 - Up Front (Page 16) Drug Topics - January 2009 - Up Front (Page 17) Drug Topics - January 2009 - Up Front in Depth (Page 18) Drug Topics - January 2009 - Up Front in Depth (Page 19) Drug Topics - January 2009 - Community Practice (Page 20) Drug Topics - January 2009 - Community Practice (Page 20a) Drug Topics - January 2009 - Community Practice (Page 20b) Drug Topics - January 2009 - Community Practice (Page 21) Drug Topics - January 2009 - Drug Pipeline: What to Watch in 2009 (Page 22) Drug Topics - January 2009 - Drug Pipeline: What to Watch in 2009 (Page 23) Drug Topics - January 2009 - Drug Pipeline: What to Watch in 2009 (Page 24) Drug Topics - January 2009 - Drug Pipeline: What to Watch in 2009 (Page 25) Drug Topics - January 2009 - Drug Pipeline: What to Watch in 2009 (Page 26) Drug Topics - January 2009 - Drug Pipeline: What to Watch in 2009 (Page 27) Drug Topics - January 2009 - OTC (Page 28) Drug Topics - January 2009 - OTC (Page 29) Drug Topics - January 2009 - OTC (Page 30) Drug Topics - January 2009 - OTC (Page 31) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 32) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 33) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 34) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 35) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 36) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 37) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 38) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 39) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 40) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 41) Drug Topics - January 2009 - New Products (Page 42) Drug Topics - January 2009 - New Products (Page 43) Drug Topics - January 2009 - New Products (Page 44) Drug Topics - January 2009 - New Products (Page 45) Drug Topics - January 2009 - New Products (Page 46) Drug Topics - January 2009 - New Products (Page 47) Drug Topics - January 2009 - Viewpoint (Page 48) Drug Topics - January 2009 - Viewpoint (Page Cover3) Drug Topics - January 2009 - Viewpoint (Page Cover4) http://digital.modernmedicine.com/nxtbooks/advanstar/dt_200912http://digital.modernmedicine.com/nxtbooks/advanstar/dt_200911http://digital.modernmedicine.com/nxtbooks/advanstar/dt_200910http://digital.modernmedicine.com/nxtbooks/advanstar/dt_200909http://digital.modernmedicine.com/nxtbooks/advanstar/dt_200908http://digital.modernmedicine.com/nxtbooks/advanstar/dt_200907http://digital.modernmedicine.com/nxtbooks/advanstar/dt_200906http://digital.modernmedicine.com/nxtbooks/advanstar/dt_200905http://www.nxtbook.com/nxtbooks/advanstar/dt_200904http://www.nxtbook.com/nxtbooks/advanstar/dt_200903http://www.nxtbook.com/nxtbooks/advanstar/dt_200902http://www.nxtbook.com/nxtbooks/advanstar/dt_200901_v2http://www.nxtbook.com/nxtbooks/advanstar/dt_200901http://www.nxtbook.com/nxtbooks/advanstar/dt122908http://www.nxtbook.com/nxtbooks/advanstar/dt122208http://www.nxtbook.com/nxtbooks/advanstar/dt121508http://www.nxtbook.com/nxtbooks/advanstar/dt111008_v2http://www.nxtbook.com/nxtbooks/advanstar/dt120808http://www.nxtbook.com/nxtbooks/advanstar/dt120108http://www.nxtbook.com/nxtbooks/advanstar/dt112408http://www.nxtbook.com/nxtbooks/advanstar/dt111708http://www.nxtbook.com/nxtbooks/advanstar/dt111008http://www.nxtbook.com/nxtbooks/advanstar/dt110308http://www.nxtbook.com/nxtbooks/advanstar/dt102708http://www.nxtbook.com/nxtbooks/advanstar/dt102008http://www.nxtbook.com/nxtbooks/advanstar/dt101308http://www.nxtbook.com/nxtbooks/advanstar/dt100608http://www.nxtbook.com/nxtbooks/advanstar/dt092908http://www.nxtbook.com/nxtbooks/advanstar/dt092208http://www.nxtbook.com/nxtbooks/advanstar/dt090808http://www.nxtbook.com/nxtbooks/advanstar/dt090108http://www.nxtbook.com/nxtbooks/advanstar/dt082508http://www.nxtbook.com/nxtbooks/advanstar/dt081808http://www.nxtbook.com/nxtbooks/advanstar/dt081108http://www.nxtbook.com/nxtbooks/advanstar/dt080408http://www.nxtbook.com/nxtbooks/advanstar/dt072808http://www.nxtbook.com/nxtbooks/advanstar/dt072108http://www.nxtbook.com/nxtbooks/advanstar/dt070708http://www.nxtbook.com/nxtbooks/advanstar/dt063008http://www.nxtbook.com/nxtbooks/advanstar/dt062308http://www.nxtbook.com/nxtbooks/advanstar/dt061608http://www.nxtbook.com/nxtbooks/advanstar/dt060908http://www.nxtbook.com/nxtbooks/advanstar/dt060208http://www.nxtbook.com/nxtbooks/advanstar/dt052608http://www.nxtbook.com/nxtbooks/advanstar/dt051908http://www.nxtbook.com/nxtbooks/advanstar/dt051208http://www.nxtbook.com/nxtbooks/advanstar/dt042808http://www.nxtbook.com/nxtbooks/advanstar/dt042108http://www.nxtbook.com/nxtbooks/advanstar/dt041408http://www.nxtbook.com/nxtbooks/advanstar/dt040708http://www.nxtbook.com/nxtbooks/advanstar/dt033108http://www.nxtbook.com/nxtbooks/advanstar/dt032408http://www.nxtbook.com/nxtbooks/advanstar/dt031708http://www.nxtbook.com/nxtbooks/advanstar/dt031008http://www.nxtbook.com/nxtbooks/advanstar/dt030308http://www.nxtbook.com/nxtbooks/advanstar/dt022508http://www.nxtbook.com/nxtbooks/advanstar/dt021808http://www.nxtbook.com/nxtbooks/advanstar/dt021108http://www.nxtbook.com/nxtbooks/advanstar/dt020408http://www.nxtbook.com/nxtbooks/advanstar/dt012808http://www.nxtbook.com/nxtbooks/advanstar/dt012108http://www.nxtbook.com/nxtbooks/advanstar/dt011408http://www.nxtbook.com/nxtbooks/advanstar/dt010708http://www.nxtbook.com/nxtbooks/advanstar/dt121707http://www.nxtbook.com/nxtbooks/advanstar/dt121007http://www.nxtbook.com/nxtbooks/advanstar/dt120307http://www.nxtbook.com/nxtbooks/advanstar/dt112607http://www.nxtbook.com/nxtbooks/advanstar/dt111907http://www.nxtbook.com/nxtbooks/advanstar/dt111207http://www.nxtbook.com/nxtbooks/advanstar/dt110507http://www.nxtbook.com/nxtbooks/advanstar/dt102907http://www.nxtbook.com/nxtbooks/advanstar/dt102207http://www.nxtbook.com/nxtbooks/advanstar/dt101507http://www.nxtbook.com/nxtbooks/advanstar/dt100807http://www.nxtbookMEDIA.com

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.